| ||||||||||||||
|
|
|||||||||||||
Department of Anesthesiology, Department of Medicine, Nephrology Division, Department of Biomedical Engineering, University of Virginia Health System, Charlottesville, Virginia
Address correspondence and reprint requests to George F. Rich, MD, PhD, Department of Anesthesiology, P.O Box 800710, University of Virginia Health System, Charlottesville, VA 22908-0710. Address e-mail to gfr2f{at}virginia.edu.
Lidocaine attenuates cell injury induced by ischemic-reperfusion and inflammation, although the protective mechanisms are not understood. We hypothesized that lidocaine and other amide local anesthetics protect against endothelial cell injury through activation of the mitochondrial adenosine triphosphate-sensitive potassium (mitoKATP) channels. We determined the effects of amide local anesthetics (lidocaine, ropivacaine, and bupivacaine), ester local anesthetics (tetracaine and procaine), one amide analog (YWI), and two non-amide local anesthetic analogs (JDA and ICM) on viability of human microvascular endothelial cells after exposure to lipopolysaccharide (LPS) in the absence or presence of the mitoKATP channel antagonist 5-hydroxydecaonate. Flavoprotein fluorescence was used to investigate the effects of local anesthetics on diazoxide-induced activation of mitoKATP channels. Lidocaine, ropivacaine, bupivicaine, YWI, JDA, and ICM attenuated by 60% to 70% the decrease in cell viability caused by LPS. Amide local anesthetics and YWI protection was inhibited by 5-hydroxydecaonate, whereas the protection induced by JDA and ICM was not. Tetracaine and procaine did not protect against LPS-induced injury. The amide local anesthetics and the amide analog (YWI) enhanced diazoxide-induced flavoprotein fluorescence by 5% to 20%, whereas ester local anesthetics decreased diazoxide-induced flavoprotein fluorescence by 5% to 60% and the non-amide local anesthetic analogs had no effect. In conclusion, amide local anesthetics and the amide analog (YWI) attenuate LPS-induced cell injury, in part, through activation of mitoKATP channels. In contrast, tetracaine and procaine had no protective effects and inhibited activation of mitoKATP channels. The non-amide local anesthetic analogs induced protection but through mechanisms independent of mitoKATP channels.
This article has been cited by other articles:
![]() |
D. O. Zamora and J. W. Kiel Topical Proparacaine and Episcleral Venous Pressure in the Rabbit Invest. Ophthalmol. Vis. Sci., June 1, 2009; 50(6): 2949 - 2952. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, M. J. Laster, E. I. Eger II, M. Sharma, and J. M. Sonner Lidocaine, MK-801, and MAC Anesth. Analg., May 1, 2007; 104(5): 1098 - 1102. [Abstract] [Full Text] [PDF] |
||||
|